<!DOCTYPE html>
<html lang="en"><head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<link href="https://cdn-icons-png.flaticon.com/512/4021/4021693.png" rel="icon"/>
<link href="../style.css" rel="stylesheet"/>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600&amp;family=Space+Mono:wght@400;700&amp;display=swap" rel="stylesheet"/>
<title>DIM</title>
</head><body><main class="container"><header class="site-header">
<h1 class="logo"><a href="../index.html">r/anhedonia</a></h1>
<p class="subtitle">Personal Wiki</p>
</header><nav style="margin-bottom: 20px;"><a href="../actions.html">← Back to Personal Wiki</a></nav><section class="card"><h2>DIM</h2><ul>
<li><img src="https://upload.wikimedia.org/wikipedia/commons/thumb/6/61/Ampelopsin.svg/250px-Ampelopsin.svg.png"/></li>
<li>Also known as: 3,3′-Diindolylmethane</li>
<li>Pharmacological Actions</li>
<li>DIM exhibits a wide range of pharmacological actions, supported by both preclinical and clinical evidence. These actions include:</li>
<ul>
<li>Antioxidant Effects: DIM reduces oxidative stress, particularly in radiation-damaged cells, through pathways like NRF2/ARE/HO-1, as noted in studies on cellular protection mechanisms (<a href="https://www.mdpi.com/2223-7747/14/5/827">source</a>).</li>
<li>Anti-inflammatory Properties: It decreases levels of pro-inflammatory markers such as NO, PGE2, TNF-α, and IL-6 in LPS-treated cells, suggesting a role in mitigating inflammation (<a href="https://www.mdpi.com/2223-7747/14/5/827">source</a>).</li>
<li>Antiapoptotic Activity: DIM increases antiapoptotic protein Bcl-2 and decreases pro-apoptotic Bax, potentially protecting cells from programmed cell death, especially in bone marrow cells post-injury (<a href="https://www.mdpi.com/2223-7747/14/5/827">source</a>).</li>
<li>Immunomodulatory Effects: DIM induces proliferation of splenocytes and augments cytokine production like IFN-γ and IL-12, with effects varying by dose and duration, such as at 100 mg/kg showing significant immune cell modulation (<a href="https://www.mdpi.com/2223-7747/14/5/827">source</a>).</li>
<li>Anticancer Properties: DIM is noted for inducing apoptosis, cell cycle arrest (e.g., G1 arrest in breast cancer cells), and inhibiting tumor growth, with mechanisms involving AKT, NF-κB, and FOXO3 pathways, supported by both in vitro and in vivo studies (<a href="https://www.webmd.com/vitamins/ai/ingredientmono-1049/diindolylmethane">source</a>).</li>
<li>Estrogen Metabolism Modulation: DIM alters estrogen metabolism, increasing the ratio of 2-hydroxyestrones to 16α-hydroxyestrone, potentially reducing risks of hormone-related cancers, as seen in thyroid proliferative disease studies (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3048776/">source</a>).</li>
<li>Histone Deacetylase Inhibition: In vitro, DIM acts as an inhibitor against HDAC1, HDAC2, and HDAC3, which may contribute to its anticancer effects (<a href="https://en.wikipedia.org/wiki/3%2C3%27-Diindolylmethane">source</a>).</li>
<li>Mild Cannabinoid Agonist: DIM shows low binding affinity for CB1 and CB2 receptors, suggesting minor cannabinoid-like effects (<a href="https://en.wikipedia.org/wiki/3%2C3%27-Diindolylmethane">source</a>).</li>
<li>Biofilm Reduction: Research indicates DIM can reduce biofilms responsible for dental plaque by up to 90%, potentially aiding oral health (<a href="https://en.wikipedia.org/wiki/3%2C3%27-Diindolylmethane">source</a>).</li>
</ul>
<li>The influence of these actions over time varies by study, with effects typically observed within hours to weeks depending on dosage and administration route. For instance, anti-inflammatory effects may peak within 24 hours at certain doses, while anticancer effects may require weeks of supplementation to manifest in clinical trials.</li>
<li>Half-Life</li>
<li>The half-life of DIM in humans, based on pharmacokinetic studies, is approximately 4.3 hours for the parent compound, with variations depending on formulation. For example, a study reported a mean noncompartmental half-life of 4.29 ± 2.48 hours, with metabolites showing longer half-lives, such as 9.34 ± 3.13 hours for monohydroxylated forms (<a href="https://link.springer.com/article/10.1186/1878-5085-4-25">source</a>).</li>
<li>Bioavailability</li>
<li>DIM's bioavailability is naturally low due to poor solubility and limited membrane penetration, particularly in its crystalline form. However, enhanced formulations like BR-DIM significantly improve absorption. In human studies, oral administration of BR-DIM resulted in a Cmax of 111 ± 160 ng/ml and Tmax of 2.67 ± 0.98 hours, indicating improved bioavailability compared to crystalline DIM (<a href="https://link.springer.com/article/10.1186/1878-5085-4-25">source</a>).</li>
<li>Dosage Considerations</li>
<li>Dosage recommendations for DIM vary based on safety, efficacy, and intended use, with the following details derived from clinical and preclinical studies:</li>
<li>Safe Range: Clinical studies suggest DIM is safe up to 150-200 mg per day. For instance, a study on single-dose pharmacokinetics found no adverse effects up to 200 mg, with mild side effects like nausea at 300 mg (<a href="https://www.webmd.com/vitamins/ai/ingredientmono-1049/diindolylmethane">source</a>).</li>
<li>Minimum Effective Dose: The minimum effective dose varies by condition, typically ranging from 100 mg to 300 mg per day. For example, studies on estrogen metabolism used 300 mg/day, while chemoprevention trials targeted doses achieving Cmax with less than 150 mg (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2602858/">source</a>).</li>
<li>Maximum Dose Without High Risks: Doses up to 200 mg per day are well-tolerated, with 300 mg showing infrequent mild side effects like nausea and headache, suggesting a threshold around this level (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2602858/">source</a>).</li>
<li>When It Starts to Become Too Dangerous: At 600 mg per day, there may be risks such as lowering sodium levels, as noted by WebMD, but exact thresholds for danger are not well-established, indicating a need for further research (<a href="https://www.mskcc.org/cancer-care/integrative-medicine/herbs/diindolylmethane">source</a>).</li>
<li>LD50: The lethal dose 50 (LD50) for DIM was not found in the available literature, suggesting it may not be determined or is not publicly documented, which underscores the need for additional toxicological studies.</li>
<li>Clinical and Safety Considerations</li>
<li>Clinical trials have used doses ranging from 50 mg to 300 mg daily, with most studies reporting DIM as safe at lower doses. However, higher doses (e.g., 300 mg) may cause mild adverse effects, and at 600 mg, potential risks like hyponatremia are noted. The lack of LD50 data highlights a gap in toxicological research, and case reports of serious side effects at excessive intakes suggest caution, particularly for vulnerable populations like pregnant women or those on hormonal therapies (<a href="https://www.webmd.com/vitamins/ai/ingredientmono-1049/diindolylmethane">source</a>).</li>
</ul></section><footer class="site-footer">
<p><a href="../index.html">← Back to Home</a></p>
</footer></main><script src="../js/router.js"></script></body></html>